NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

QT Ultrasound Delivers the First 3D Printing of Human Breast Microanatomy In Vivo

QT Ultrasound, the developer of the only FDA-cleared transmission ultrasound breast imaging technology, has now created the first 3D printing of the breast duct system in a living woman, using its technology.

Transmission ultrasound can image microanatomy in living humans and can isolate human tissue types using speed of sound. QT Ultrasound’s first application of their technology is breast imaging and the QTscan™, was cleared for marketing by the FDA in 2017. Unlike traditional breast imaging, the QTscan has no radiation, no compression, and no injections, which makes it a welcome addition to the arsenal of breast health modalities. The technology produces high-fidelity detailed scans, providing clarity even for women with dense breasts.

Beyond the accomplishments of this new imaging modality, the company has now demonstrated that the technology has the ability to produce 3D printed images of a person’s breast tissue-specific microanatomy. This is the first example of 3D printing of human breast tissue-specific microanatomy using any medical imaging modality and has the potential to be a new diagnostic tool, and a new way for physicians to visualize human health and disease.

“We are on a mission to change the paradigm of breast imaging,” says QT Ultrasound’s CEO, Dr. John Klock. “Transmission ultrasound provides high definition imaging of breast tissue, and we’re excited to show why true 3D data acquisition and image reconstruction matters. The benefits of being able to see breast tissue information in a true 3D volume, and then segment and isolate the tissue types, include new opportunities to examine the ductal network of the female breast in ways we never could before.”

In 2018, the Food and Drug Administration (FDA) granted QT Ultrasound Breakthrough Device designation for its QT Scanner, potentially offering new opportunities for earlier and more frequent screening for young women at high risk for breast cancer who have no available FDA-cleared screening options.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open